Source:http://linkedlifedata.com/resource/pubmed/id/15143976
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2004-5-17
|
pubmed:abstractText |
Until recently radiotherapy of hepatic malignancies has played a limited role due to the well-known limited radiotolerance of the liver. The aim of this paper is to review the available data on the risk of radiation-induced liver disease (RILD) and to define the modern role of radiotherapy in the management of patients with metastatic or primary liver malignancies.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0300-8916
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
90
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
73-9
|
pubmed:dateRevised |
2008-12-12
|
pubmed:meshHeading |
pubmed-meshheading:15143976-Dose Fractionation,
pubmed-meshheading:15143976-Humans,
pubmed-meshheading:15143976-Liver,
pubmed-meshheading:15143976-Liver Diseases,
pubmed-meshheading:15143976-Liver Neoplasms,
pubmed-meshheading:15143976-Radiotherapy, Conformal,
pubmed-meshheading:15143976-Radiotherapy Planning, Computer-Assisted,
pubmed-meshheading:15143976-Stereotaxic Techniques
|
pubmed:articleTitle |
Radiotherapy of liver malignancies. From whole liver irradiation to stereotactic hypofractionated radiotherapy.
|
pubmed:affiliation |
Division of Radiation Oncology, European Institute of Oncology, Milan, Italy. carlo.greco@ieo.it
|
pubmed:publicationType |
Journal Article,
Review
|